Cargando…
The urgency to expand the antiviral indications of general chronic hepatitis B patients
In recent years, liver experts have conducted in-depth discussions on whether it is necessary to expand the indication of antiviral therapy for patients with chronic hepatitis B (CHB). Currently, the guidelines are too strict in treating CHB patients. With the deepening understanding of the natural...
Autores principales: | Fan, Ping, Li, Lan-Qing, Chen, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235492/ https://www.ncbi.nlm.nih.gov/pubmed/37275355 http://dx.doi.org/10.3389/fmed.2023.1165891 |
Ejemplares similares
-
Dynamics of Hepatitis B Virus Pregenomic RNA in Chronic Hepatitis B Patients With Antiviral Therapy Over 9 Years
por: Pan, Jiali, et al.
Publicado: (2022) -
Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA
por: Zhou, Jing, et al.
Publicado: (2022) -
Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
por: Zhou, Jing, et al.
Publicado: (2021) -
Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
por: Zhang, Sihui, et al.
Publicado: (2023) -
Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver Failure
por: Wang, Meng-Lan, et al.
Publicado: (2021)